Prevalence of DSM-5 somatic symptom disorder in Chinese patients with breast cancer.
China
breast cancer
health anxiety
prevalence
somatic symptom disorder
Journal
Psycho-oncology
ISSN: 1099-1611
Titre abrégé: Psychooncology
Pays: England
ID NLM: 9214524
Informations de publication
Date de publication:
08 2022
08 2022
Historique:
revised:
09
02
2022
received:
02
10
2021
accepted:
19
03
2022
pubmed:
31
3
2022
medline:
10
8
2022
entrez:
30
3
2022
Statut:
ppublish
Résumé
The aims of this study were to explore the frequency of somatic symptom disorder (SSD) and the relationship between SSD and somatic, psychological, and social factors in Chinese patients with breast cancer. This multicenter cross-sectional study enrolled 264 patients with breast cancer from three different departments in Beijing. The structured clinical interview for fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (SCID-5) for SSD. Standardized questionnaires and clinical data were used to compare patients with and without SSD. Somatic symptom disorder was diagnosed in 21.6% (57/264) of all enrolled patients. No differences were found between SSD patients and non-SSD patients in terms of sociodemographic characteristics and tumor-specific variables, except radiotherapy. However, patients with SSD reported higher levels of depression, anxiety and cancer-related worry. They also showed a longer duration of symptoms, greater impairment in daily life, more concern over their physical complaints and more doctor visits. In a stepwise binary logistic regression analysis, among others, higher health anxiety (WI-8, Exp(B) = 0.107, p = 0.009) and more doctor visits (OR = -1.841, p < 0.001) showed a significant association with SSD; the model explained 53.7% of the variance. Similar to other physical diseases, there is a high prevalence of SSD in patients with breast cancer. Somatic symptom disorder patients differ from non-SSD patients by exhibiting higher cancer-related emotional distress and dysfunctional illness perception and behavior. There remain substantial challenges in the diagnosis of SSD in patients with cancer and other medical conditions. ChiCTR2100051525.
Banques de données
ChiCTR
['ChiCTR2100051525']
Types de publication
Journal Article
Multicenter Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1302-1312Informations de copyright
© 2022 The Authors. Psycho-Oncology published by John Wiley & Sons Ltd.
Références
Cao M, Li H, Sun D, Chen W. Cancer burden of major cancers in China: a need for sustainable actions. Cancer Commun. 2020;40:205-210.
Li Z, Li J, Tang L, Pang Y. Development of psychosocial oncology care in China: consultation-liaison psychiatric service in a cancer center. Psycho Oncol. 2019;28(11):2247-2249.
Chaturvedi SK, Maguire GP, Somashekar BS. Somatization in cancer. Int Rev Psychiatr. 2006;18:49-54.
Leonhart R, Tang L, Pang Y, et al. Physical and psychological correlates of high somatic symptom severity in Chinese breast cancer patients. Psycho Oncol. 2017;26(5):656-663.
Kroenke K, Zhong X, Theobald D, Wu J, Tu W, Carpenter JS. Somatic symptoms in patients with cancer experiencing pain or depression: prevalence, disability, and health care use. Arch Intern Med. 2010;170:1686-1694.
Diagnostic and Statistical Manual of Mental Disorders. 5th ed. (DSM-5). American Psychiatric Association; 2013.
Rief W, Martin A. How to use the new DSM-5 somatic symptom disorder diagnosis in research and practice: a critical evaluation and a proposal for modifications. Annu Rev Clin Psychol. 2014;10:339-367.
Gan JJ, Lin A, Samimi MS, Mendez MF. Somatic symptom disorder in semantic dementia: the role of alexisomia. Psychosomatics. 2016;57(6):598-604.
Häuser W, Bialas P, Welsch K, Wolfe F. Construct validity and clinical utility of current research criteria of DSM-5 somatic symptom disorder diagnosis in patients with fibromyalgia syndrome. J Psychosom Res. 2015;78(6):546-552.
Klaus K, Fischer S, Doerr JM, Nater UM, Mewes R. Classifying fibromyalgia syndrome as a mental disorder?-An ambulatory assessment study. Int J Behav Med. 2017;24(2):230-238.
Newby JM, Hobbs MJ, Mahoney AE, Wong SK, Andrews G. DSM-5 illness anxiety disorder and somatic symptom disorder: comorbidity, correlates, and overlap with DSM-IV hypochondriasis. J Psychosom Res. 2017;101:31-37.
Kop WJ, Toussaint A, Mols F, Löwe B. Somatic symptom disorder in the general population: associations with medical status and health care utilization using the SSD-12. Gen Hosp Psychiatr. 2019;56:36-41.
Cao J, Wei J, Fritzsche K, et al. Prevalence of DSM-5 somatic symptom disorder in Chinese outpatients from general hospital care. Gen Hosp Psychiatr. 2020;62:63-71.
Zhang Y, Fritzsche K, Leonhart R, et al. Dysfunctional illness perception and illness behaviour associated with high somatic symptom severity and low quality of life in general hospital outpatients in China. J Psychosom Res. 2014;77:187-195.
Jiang Y, Wei J, Fritzsche K, et al. Assessment of the structured clinical interview (SCID) for DSM-5 for somatic symptom disorder in general hospital outpatient clinics in China. BMC Psychiatr. 2021;21:144. https://doi.org/10.1186/s12888-021-03126-0
Kroenke K, Spitzer RL, Williams JB. The PHQ-15: validity of a new measure for evaluating the severity of somatic symptoms. Psychosom Med. 2002;64(2):258-266.
Toussaint A, Hüsing P, Kohlmann S, Löwe B. Detecting DSM-5 somatic symptom disorder: criterion validity of the Patient Health Questionnaire-15 (PHQ-15) and the Somatic Symptom Scale-8 (SSS-8) in combination with the Somatic Symptom Disorder-B Criteria Scale (SSD-12). Psychol Med. 2020;50(2):324-333.
Qian J, Ren ZQ, Yu DH, He XY, Li CB. The value of the Patient Health Questionnaire-15 (PHQ-15) for screening somatic symptoms in general hospital. Chin Ment Health J. 2014;28(3):173-178.
Kroenke K, Spitzer RL, Williams JBW. The PHQ-9: validity of a brief depression severity measure. J General Intern Med. 2001;16(9):606-613.
Xiong N, Fritzsche K, Wei J, et al. Validation of Patient Health Questionnaire (PHQ) for major depression in Chinese outpatients with multiple somatic symptoms: a multicenter cross-sectional study. J Affect Disord. 2015;174:636-643.
He X, Li C, Qian J, Cui H, Wu W. Reliability and validity of a generalized anxiety disorder scale in general hospital outpatients. Shanghai Arch Psychiatry. 2010;22(4):200-203.
Qu S, Sheng L. Diagnostic test of screening generalized anxiety disorders in general hospital psychological department with GAD-7. Chin Ment Health J. 2015;29(12):939-944.
Fink P, Ewald H, Jensen J, et al. Screening for somatization and hypochondriasis in primary care and neurological inpatients: a seven-item scale for hypochondriasis and somatization. J Psychosom Res. 1999;46:261-273.
Carstensen TBW, Ørnbøl E, Fink P, et al. Detection of illness worry in the general population: a specific item on illness rumination improves the Whiteley Index. J Psychosom Res. 2020;138:110245.
Lee S, Ng KL, Ma YL, Tsang A, Kwok KP. A general population study of the Chinese Whiteley-7 Index in Hong Kong. J Psychosom Res. 2011;71:387-391.
Tu CY, Liao SC, Liu CY, et al. Application of the Chinese version of the Whiteley Index-7 for detecting DSM-5 somatic symptom and related disorders. Psychosomatics. 2016;57:283-291.
Chen Y, Wu H, Shao Q, et al. Psychometric evaluation of the Whiteley Index-8 in Chinese outpatients in general hospitals. Front Psychol. 2021;12:557662.
Thewes B, Butow P, Zachariae R, Christensen S, Simard S, Gotay C. Fear of cancer recurrence: a systematic literature review of self-report measures. Psycho Oncol. 2012;21(6):571-587.
Humphris GM, Watson E, Sharpe M, Ozakinci G. Unidimensional scales for fears of cancer recurrence and their psychometric properties: the FCR4 and FCR7. Health Qual Life Outcome. 2018;16(1):30.
Hirai K, Shiozaki M, Motooka H, et al. Discrimination between worry and anxiety among cancer patients: development of a Brief Cancer-Related Worry Inventory. Psycho Oncol. 2008;17(12):1172-1179.
Moye J, Wachen JS, Mulligan EA, Doherty K, Naik AD. Assessing multidimensional worry in cancer survivors. Psycho Oncol. 2014;23(2):237-240.
Löwe B, Spitzer RL, Williams JB, Mussell M, Schellberg D, Kroenke K. Depression, anxiety and somatization in primary care: syndrome overlap and functional impairment. Gen Hosp Psychiatr. 2008;30:191-199.
Toussaint A, Murray AM, Voigt K, et al. Development and validation of the Somatic Symptom Disorder-B Criteria Scale (SSD-12). Psychosom Med. 2016;78:5-12.
Chander KR, Manjunatha N, Binukumar B, Kumar CN, Bada MS, Janardhan RYC. The prevalence and its correlates of somatization disorder at a quaternary mental health centre. Asian J Psychiatr. 2019;42:24-27.
Creed FH, Davies I, Jackson J, et al. The epidemiology of multiple somatic symptoms. J Psychosom Res. 2012;72:311-317.
Kurlansik SL, Maffei MS. Somatic symptom disorder. Am Fam Physician. 2016;93(1):49-54.
Yates WR, Dunayevich E. Somatic Symptom Disorders. Medscape; 2014. http://emedicine.medscape.com/article/294908-overview
Lee S, Creed FH, Ma YL, Leung CM. Somatic symptom burden and health anxiety in the population and their correlates. J Psychosom Res. 2015;78(1):71-76.
Levenson JL. Somatic symptom disorder: epidemiology and clinical presentation. 2021. https://www.uptodate.com/contents/somatic-symptom-disorder-epidemiology-and-clinical-presentation/print
Kirmayer LJ, Sartorius N. Cultural models and somatic syndromes. Psychosom Med. 2007;69:832-840.